BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1212813)

  • 1. Formalinized tumour cells in the leucocyte migration inhibition test.
    Ross CE; Cochran AJ; Hoyle DE; Grant RM; Mackie RM
    Clin Exp Immunol; 1975 Oct; 22(1):126-32. PubMed ID: 1212813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
    Cochran AJ; Spilg WG; Mackie RM; Thomas CE
    Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane associated antigens of human malignant melanoma. II. Leucocyte migration studies with formalin fixed human melanoma cells.
    Suter L; Sorg C; Macher E
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):242-9. PubMed ID: 134542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
    Isbister WH
    N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure to demonstrate tumour-specific leucocyte migration inhibition in vitro by cryostat sections of breast cancer tissue.
    Petrini B; Bergstrand A; Wasserman J; Blomstedt B; Blomgren H; Baral E
    Clin Oncol; 1977 Sep; 3(3):259-66. PubMed ID: 912961
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
    Tosner J; Fixa B
    Clin Exp Immunol; 1979 Nov; 38(2):356-60. PubMed ID: 527267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium.
    Chee DO; Boddie AW; Roth JA; Holmes EC; Morton DL
    Cancer Res; 1976 Apr; 36(4):1503-9. PubMed ID: 1260767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
    Nifontova TP
    Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte migration inhibition by cancer patients' sera.
    Cochran AJ; Mackie RM; Ross CE; Ogg LJ; Jackson AM
    Int J Cancer; 1976 Sep; 18(3):274-81. PubMed ID: 1066319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity of a fetal extract in the leucocyte migration-inhibition test.
    Uehara Y; Kojima O; Kitagawa N; Oh A; Nishioka B; Fujita Y; Majima S
    Oncodev Biol Med; 1983; 4(5):335-41. PubMed ID: 6856483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NK function elucidated with respect to effector cells, target cells and other immunological in vitro tests.
    Kristensen E
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):449-53. PubMed ID: 6681340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of leukocyte migration with melanoma-associated antigens in choroidal tumors.
    Char DH
    Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):176-9. PubMed ID: 832980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity to breast carcinoma and malignant melanoma.
    Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
    Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modification of a micromethod for determining leukocyte migration inhibition and its significance in oncological patients].
    Kochetkova VA
    Lab Delo; 1980; (12):744-6. PubMed ID: 6163894
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic and survival studies in mice immunised with cryodestroyed ascites fibrosarcoma (AFS) cells.
    Roy A; Lahiri S; Lahiri P; Pal S; Ghosh S; Roy B
    Indian J Exp Biol; 1990 Nov; 28(11):1026-30. PubMed ID: 2283170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.